Skip to main content
Fig. 5 | Antimicrobial Resistance & Infection Control

Fig. 5

From: In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase–producing Klebsiella pneumoniae

Fig. 5

Bacterial burden in blood, spleen and liver of mice at 3 days post infection (dpi). Mice were infected with 2.5 × 106 CFU of strain Y8 via the ip route and then treated with PBS or ceftazidime-avibactam by subcutaneous injection. At 3dpi, the viable bacteria of blood, spleen and liver was determined by plating serial dilutions on agar plates (n = 8). ∗P < 0.05; ∗∗P < 0.01

Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us